the optimal dosing strategy for regorafenib in mcrc
Published 5 years ago • 71 plays • Length 8:18Download video MP4
Download video MP3
Similar videos
-
3:18
a dose-escalation study of regorafenib in mcrc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
8:32
dose optimization for improved outcomes in refractory mcrc
-
6:49
achieving a durable response with regorafenib in mcrc
-
1:47
alan venook, md relays the optimal dose for regorafenib (stivarga) in the 2nd line treatment of mcrc
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
7:43
therapy in the salvage setting of mcrc
-
2:11
expert reviews redos trial results in mcrc
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
5:31
practical advice for using regorafenib
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
1:39
dr. van cutsem discusses regorafenib for the treatment of patients with chemorefractory mcrc
-
6:33
patient selection for regorafenib in crc
-
5:03
toxicity management for third-line therapy for mcrc
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer